| Line Item | 2021-03-31 | Y/Y |
|---|---|---|
| Revenue | $2.70B | — |
| Cost of Revenue | $539.6M | — |
| Gross Profit | $2.16B | — |
| R&D Expense | $543.4M | — |
| SG&A Expense | $274.6M | — |
| Operating Income | $403.8M | — |
| Pre-tax Income | $385.4M | — |
| Income Tax | $63.2M | — |
| Net Income | $322.2M | — |
| Line Item | 2021-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $758.0M | +32.3% |
| Short-term Investments | $126.6M | -49.0% |
| Accounts Receivable | $470.0M | +38.8% |
| Inventory | $68.4M | +120.9% |
| Current Assets | $1.91B | +35.7% |
| Total Assets | $5.28B | +18.8% |
| Current Liabilities | $1.84B | +47.0% |
| Line Item | 2021-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $442.6M | — |
| Capital Expenditures | $33.6M | — |
| Investing Cash Flow | $218.1M | — |
| Financing Cash Flow | -$476.5M | — |
| Free Cash Flow | $409.0M | — |
| EPS (Basic) | $5.34 | — |
| EPS (Diluted) | $5.27 | — |
| Long-term Debt |
| $0 |
| -100.0% |
| Stockholders' Equity | $2.47B | +23.6% |